As far as I can see the only thing the bacteria are doing is reductively aminating a phenyl-2-propane giving the amine, there is no suggestion they can aminate a phenylpropene, so forget essential oils. accessing interesting P2Ps would be the single biggest barrier to someone wanting to do this clandestinely. Nobody in the DEA is going to be losing sleep worrying about the biosynthesis of amphetamines anytime soon.
the reduction is enantioselective, so chiral AMP's can be made from an achiral P2P which is perhaps useful, though there are much better or easier ways of making pure enantiomers of amphetamines without bacteria and the very low volumetric efficiency bioconversion offers, yeast does the same thing. There are also lots and lots of other ways of reductively aminating P2P compounds.
separation of the product from the starting materials and by-products is trivial.
this is just an interesting novelty.
Biosynthesis and GM biosynthesis has its place, being able to produce ergolines for example using something easy to culture and without using claviceps species would have significant economic value
The biosynthesis of morphine is another, however this is more politically than economically driven, growing poppies is ubercheap, but the governments don't like it and would much prefer to pay academics vast amounts of money to develop the biotechnology to produce morphine in reactors under full government control.